Preeclampsia in 2018: Revisiting Concepts, Physiopathology, and Prediction
Open accessThe DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Abstract
Preeclampsia currently remains one of the leading causes of death and severe maternal morbidity. Although its prevalence is still underestimated in some places due to underreporting, preeclampsia is a disease that health professionals need to know how to deal with and take action. For this reason, the studies about the theme remain along with the advances in their understanding that often implies improvement and change of concepts and conducts. The complexity of its etiology is a challenge and requires further studies for its full understanding. Apparently, poor adaptation of the maternal organism to the conceptus, marked by the nonoccurrence of changes in the uterine spiral arteries, determines a series of systemic repercussions that compound the various forms of preeclampsia presentation. In recent years, the use of acetylsalicylic acid to prevent cases of early onset of the disease has been consolidated and, alongside, studies have advanced the development of accessible and effective methods of identifying women at risk of preeclampsia. The aim of this review is to discuss updates on the occurrence, concept, pathophysiology, repercussion, prevention, and prediction of preeclampsia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global causes of maternal death: a WHO systematic analysis
Say, L., Chou, D., Gemmill, A., Tunçalp, Ö., Moller, A.-B., Daniels, J., Gülmezoglu, A. M., Temmerman, M., & Alkema, L. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(14)70227-x · Cited by 6,582
(2013) · doi:10.1097/01.aog.0000437382.03963.88 · Cited by 3,961
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. J. (2007) · BMJ · doi:10.1136/bmj.39335.385301.be · Cited by 2,552 · cited 1×
“Similarly, the risk of acute myocardial infarction, stroke, and venous thromboembolism is substantially higher in women with a personal history of preeclampsia, as demonstrated in a meta-analysis published in 2007 [41].”
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
Rolnik, D. L., Wright, D., Poon, L. C., O’Gorman, N., Syngelaki, A., de Paco Matallana, C., Akolekar, R., Cicero, S., Janga, D., Singh, M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1704559 · Cited by 2,287
Onuegbu, A. J., Olisekodiaka, J. M., Udo, J. U., Umeononihu, O., Amah, U. K., Okwara, J. E., & Atuegbu, C. (2015) · Medical Principles and Practice · doi:10.1159/000381778 · Cited by 2,044
Brown, M. A., Lindheimer, M. D., Swiet, M. D., Assche, A. V., & Moutquin, J.-M. (2001) · Hypertension in Pregnancy · doi:10.1081/prg-100104165 · Cited by 1,894 · cited 1×
“As it can be noticed, proteinuria is not a sine qua non condition to characterize preeclampsia, as previously ensued [22, 23].”
Global and regional estimates of preeclampsia and eclampsia: a systematic review
Abalos, E., Cuesta, C., Grosso, A. L., Chou, D., & Say, L. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.05.005 · Cited by 1,574
The “Great Obstetrical Syndromes” are associated with disorders of deep placentation
Brosens, I., Pijnenborg, R., Vercruysse, L., & Romero, R. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.08.009 · Cited by 1,568 · cited 2×
“The remodeling of the spiral arteries occurs more in the central part of the placental bed, reducing progressively towards the periphery [30].”
Tranquilli, A. L., Dekker, G., Magee, L., Roberts, J., Sibai, B. M., Steyn, W., Zeeman, G. G., & Brown, M. A. (2014) · Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health · doi:10.1016/j.preghy.2014.02.001 · Cited by 1,417 · cited 4×
“(c) Uteroplacental dysfunctions: fetal growth restriction; changes in the Doppler velocimetry studies of the umbilical artery, especially if combined with alterations in uterine arteries [20, 21].”
InfluentialThe Uterine Spiral Arteries In Human Pregnancy: Facts and Controversies
Pijnenborg, R., Vercruysse, L., & Hanssens, M. (2006) · Placenta · doi:10.1016/j.placenta.2005.12.006 · Cited by 1,205
Burton, G. J., Woods, A. W., Jauniaux, E., & Kingdom, J. C. P. (2009) · Placenta · doi:10.1016/j.placenta.2009.02.009 · Cited by 1,188 · cited 2×
“It can be said that such a process is immunomediated, as it involves systemic inflammatory response and maternal genetic predisposition [34, 36, 37].”
Brown, M. A., Magee, L. A., Kenny, L. C., Karumanchi, S. A., McCarthy, F. P., Saito, S., Hall, D. R., Warren, C. E., Adoyi, G., & Ishaku, S. (2018) · Pregnancy Hypertension · doi:10.1016/j.preghy.2018.05.004 · Cited by 1,067 · cited 1×
“According to the concept proposed by the International Society for Studies in Gestational Hypertension, published in 2014 and reinforced in 2018 [24], every hypertensive pregnant woman should be investigated for multiple organ involvement, even if presenting negative proteinuria, in order to discard the hypothesis of…”
Risks associated with obesity in pregnancy, for the mother and baby: a systematic review of reviews
Marchi, J., Berg, M., Dencker, A., Olander, E. K., & Begley, C. (2015) · Obesity Reviews · doi:10.1111/obr.12288 · Cited by 991 · cited 1×
“Preexisting pathological conditions such as chronic hypertension, diabetes mellitus, nephropathy, and antiphospholipid antibody syndrome are also included in the list [21, 57], as well as BMI above 35 and use of assisted reproductive technologies [58, 59].”
Maternal near miss – towards a standard tool for monitoring quality of maternal health care
Say, L., Souza, J. P., & Pattinson, R. C. (2009) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2009.01.007 · Cited by 961
Pre-eclampsia part 1: current understanding of its pathophysiology
Chaiworapongsa, T., Chaemsaithong, P., Yeo, L., & Romero, R. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.102 · Cited by 956 · cited 2×
“On the other hand, the radial and arched arteries will have increased blood pressure in their walls, resulting from the higher blood flow, which will act as a stress producer and, ultimately, will generate nitric oxide secretion by the endothelium, determining an overall vasodilation of the uterine vessels [35].”
Maternal Mortality From Preeclampsia/Eclampsia
Ghulmiyyah, L., & Sibai, B. (2012) · Seminars in Perinatology · doi:10.1053/j.semperi.2011.09.011 · Cited by 842 · cited 2×
“Preeclampsia and eclampsia rank second or third in the world ranking of maternal morbidity and mortality causes [5].”
Why is placentation abnormal in preeclampsia?
Fisher, S. J. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.08.042 · Cited by 630 · cited 1×
“It is likely to be elapsed fromamodel composed of two interrelated stages: abnormal placentation and maternal inflammatory response [31, 32].”
Preeclampsia: An imbalance in placental prostacyclin and thromboxane Production
Walsh, S. W. (1985) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(85)80223-4 · Cited by 601 · cited 1×
“Otherwise, the synthesis of thromboxane A2 is increased in placentas of women with preeclampsia, which determines the predominance of vasoconstriction and increased platelet aggregation [39], as well as thrombin, which has its maximum expression in disseminated intravascular coagulation, clinically translated to place…”
Burton, G. J., Yung, H.-W., Cindrova-Davies, T., & Charnock-Jones, D. S. (2009) · Placenta · doi:10.1016/j.placenta.2008.11.003 · Cited by 502 · cited 2×
“The last step is that of vessel reendothelialization and other induced maternal adaptations [30, 33].”
Preeclampsia; short and long-term consequences for mother and neonate
Bokslag, A., van Weissenbruch, M., Mol, B. W., & de Groot, C. J. M. (2016) · Early Human Development · doi:10.1016/j.earlhumdev.2016.09.007 · Cited by 469 · cited 3×
“In this group, arterial hypertension is defined as systolic blood pressure equal to or greater than 140 mmHg and/or diastolic blood pressure equal to or greater than 90 mmHg, which should be measured on two distant occasions at least 4-6 hours apart, in a calibrated and adequate blood pressure monitor for the biotype…”
Inflammation and pre-eclampsia
Borzychowski, A. M., Sargent, I. L., & Redman, C. W. G. (2006) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2006.04.001 · Cited by 456
Screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation
Tan, M. Y., Syngelaki, A., Poon, L. C., Rolnik, D. L., O'Gorman, N., Delgado, J. L., Akolekar, R., Konstantinidou, L., Tsavdaridou, M., Galeva, S., et al. (2018) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.19112 · Cited by 438
Bilano, V. L., Ota, E., Ganchimeg, T., Mori, R., & Souza, J. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091198 · Cited by 410 · cited 1×
“As it has already been demonstrated, a number of more than 8 prenatal visits is a protective factor for the occurrence of preeclampsia [17].”
Roberge, S., Villa, P., Nicolaides, K., Giguère, Y., Vainio, M., Bakthi, A., Ebrashy, A., & Bujold, E. (2012) · Fetal Diagnosis and Therapy · doi:10.1159/000336662 · Cited by 381 · cited 1×
“It has already been demonstrated by a meta-analysis that early use (before the 16th week of pregnancy) of low-dose aspirin reduces the occurrence of preeclampsia, especially in its more severe forms (before 34 weeks) [45].”
O'Gorman, N., Wright, D., Poon, L. C., Rolnik, D. L., Syngelaki, A., de Alvarado, M., Carbone, I. F., Dutemeyer, V., Fiolna, M., Frick, A., et al. (2017) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.17455 · Cited by 369 · cited 1×
“In addition, this institution does not recognize different scales for risk factors; thus they categorize them all under the same denomination of “high risk” [64].”
Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity
Redman, C. W. G., & Staff, A. C. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.08.003 · Cited by 361 · cited 1×
“It is likely to be elapsed fromamodel composed of two interrelated stages: abnormal placentation and maternal inflammatory response [31, 32].”
Turning the Pyramid of Prenatal Care
Nicolaides, K. H. (2011) · Fetal Diagnosis and Therapy · doi:10.1159/000324320 · Cited by 357
Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study.
Rc, G. (1991) · PubMed · Cited by 356
Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach
Poon, L. C. Y., Kametas, N. A., Chelemen, T., Leal, A., & Nicolaides, K. H. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2009.45 · Cited by 330 · cited 1×
“It had a rate of 5% of false-positive and it studied a heterogeneous population, composed of nulliparous and multiparous [12].”
Potential markers of preeclampsia – a review
Grill, S., Rusterholz, C., Zanetti-Dällenbach, R., Tercanli, S., Holzgreve, W., Hahn, S., & Lapaire, O. (2009) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-7-70 · Cited by 293
Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study.
Easterling, T. R., Benedetti, T. J., Schmucker, B. C., & Millard, S. P. (1990) · PubMed · Cited by 289
Costantine, M. M., Cleary, K., Hebert, M. F., Ahmed, M. S., Brown, L. M., Ren, Z., Easterling, T. R., Haas, D. M., Haneline, L. S., Caritis, S. N., et al. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.12.038 · Cited by 275
Robust Early Pregnancy Prediction of Later Preeclampsia Using Metabolomic Biomarkers
Kenny, L. C., Broadhurst, D. I., Dunn, W., Brown, M., North, R. A., McCowan, L., Roberts, C., Cooper, G. J. S., Kell, D. B., & Baker, P. N. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.157297 · Cited by 269
Yu, C. K. H., Smith, G. C. S., Papageorghiou, A. T., Cacho, A. M., & Nicolaides, K. H. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.06.010 · Cited by 263
O'Gorman, N., Wright, D., Poon, L. C., Rolnik, D. L., Syngelaki, A., Wright, A., Akolekar, R., Cicero, S., Janga, D., Jani, J., et al. (2017) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.17399 · Cited by 259 · cited 1×
“It is noteworthy that, when analyzed specifically for cases of early manifestation (before 34 weeks), PAPP-A and PlGF demonstrated better results [74, 75], which draws our attention to the challenge that the preeclampsia prediction may represent, considering its phenotypes variety.”
Romero, R., Erez, O., Hüttemann, M., Maymon, E., Panaitescu, B., Conde-Agudelo, A., Pacora, P., Yoon, B. H., & Grossman, L. I. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.06.003 · Cited by 253
Yu, C. K. H., Smith, G. C. S., Papageorghiou, A. T., Cacho, A. M., & Nicolaides, K. H. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.12.014 · Cited by 249 · cited 2×
“8% and the specificity was of 95% for early preeclampsia prediction [70].”
Poon, L. C. Y., Musci, T., Song, K., Syngelaki, A., & Nicolaides, K. H. (2013) · Fetal Diagnosis and Therapy · doi:10.1159/000346806 · Cited by 247
Pacagnella, R. C., Cecatti, J. G., Parpinelli, M. A., Sousa, M. H., Haddad, S. M., Costa, M. L., Souza, J. P., Pattinson, R. C., & the Brazilian Network for the Surveillance of Severe Maternal Morbidity study group (2014) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-14-159 · Cited by 245 · cited 1×
“In the last 50 years, there has been a decreasing trend in the incidence of these aggravations in high-income countries, alongside an opposite movement in middle- and low-income countries, which is basically due to access to quality prenatal care as well as adequate management of cases of preeclampsia and eclampsia, w…”
Self-citationManagement of hypertensive disorders during pregnancy: summary of NICE guidance
Visintin, C., Mugglestone, M. A., Almerie, M. Q., Nherera, L. M., James, D., Walkinshaw, S., & on behalf of the Guideline Development Group (2010) · BMJ · doi:10.1136/bmj.c2207 · Cited by 244
Cnossen, J. S., Vollebregt, K. C., Vrieze, N. D., Riet, G. T., Mol, B. W. J., Franx, A., Khan, K. S., & Post, J. A. M. V. D. (2008) · BMJ · doi:10.1136/bmj.39540.522049.be · Cited by 241 · cited 1×
“Among women at high risk for preeclampsia, it is the diastolic blood pressure above 75mmHg that exhibits the greatest predictive capacity of the disease in question [67].”
Kenny, L. C., Black, M. A., Poston, L., Taylor, R., Myers, J. E., Baker, P. N., McCowan, L. M., Simpson, N. A. B., Dekker, G. A., Roberts, C. T., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03578 · Cited by 227 · cited 1×
“Specifically for nulliparous women, a multicenter study conducted among more than 8,000 women with low-risk pregnancy demonstrated a 37% detection rate for preeclampsia using a predictor model composed exclusively of clinical factors [14]; obesity and primiparity appeared as the main demographic predictor elements of…”
Clinical Risk Factors for Preeclampsia in the 21st Century
Paré, E., Parry, S., McElrath, T. F., Pucci, D., Newton, A., & Lim, K.-H. (2014) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000451 · Cited by 208 · cited 1×
“Preexisting pathological conditions such as chronic hypertension, diabetes mellitus, nephropathy, and antiphospholipid antibody syndrome are also included in the list [21, 57], as well as BMI above 35 and use of assisted reproductive technologies [58, 59].”
First-Trimester Prediction of Preeclampsia in Nulliparous Women at Low Risk
Myatt, L., Clifton, R. G., Roberts, J. M., Spong, C. Y., Hauth, J. C., Varner, M. W., Thorp, J. M., Mercer, B. M., Peaceman, A. M., Ramin, S. M., et al. (2012) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3182571669 · Cited by 192
Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review
Thangaratinam, S., Coomarasamy, A., O'Mahony, F., Sharp, S., Zamora, J., Khan, K. S., & Ismail, K. M. (2009) · BMC Medicine · doi:10.1186/1741-7015-7-10 · Cited by 177
Preeclampsia: Syndrome or Disease?
Myatt, L., & Roberts, J. M. (2015) · Current Hypertension Reports · doi:10.1007/s11906-015-0595-4 · Cited by 175
Ramos, J. G. L., Sass, N., & Costa, S. H. M. (2017) · Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics · doi:10.1055/s-0037-1604471 · Cited by 174 · cited 1×
“As indicated by studies, this resource would be very useful to predict cases of early preeclampsia and, when applied in pregnant women who are considered to be at high risk, to evaluate the development of the disease [69].”
Estienne, A., Bongrani, A., Reverchon, M., Ramé, C., Ducluzeau, P.-H., Froment, P., & Dupont, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184431 · Cited by 173
First‐trimester maternal factors and biomarker screening for preeclampsia
Poon, L. C., & Nicolaides, K. H. (2014) · Prenatal Diagnosis · doi:10.1002/pd.4397 · Cited by 170 · cited 2×
“It is necessary to emphasize that Doppler performance is entirely dependent on the availability of the ultrasound device (which is not always a reality depending on the considered clinical center), on the examiner, and on his or her expertise and training, which restricts its use on a large scale [53].”
Hypertensive disorders during pregnancy and health outcomes in the offspring: a systematic review
Pinheiro, T. V., Brunetto, S., Ramos, J. G. L., Bernardi, J. R., & Goldani, M. Z. (2016) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174416000209 · Cited by 163 · cited 1×
“Some studies have already shown a negative impact on the neurocognitive development of these infants evaluated in their first two years of life [42, 43].”
Placental pathology suggesting that preeclampsia is more than one disease
Nelson, D. B., Ziadie, M. S., McIntire, D. D., Rogers, B. B., & Leveno, K. J. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.09.010 · Cited by 158
Thomopoulos, C., Tsioufis, C. P., Michalopoulou, H., Makris, T., Papademetriou, V., & Stefanadis, C. (2012) · Journal of Human Hypertension · doi:10.1038/jhh.2012.13 · Cited by 147 · cited 1×
“The latter is associated with a higher incidence of multiple pregnancies and with an increase in the average age of women in their first pregnancy, which together act to increase the occurrence of preeclampsia [60, 61].”
First‐trimester uterine artery Doppler indices in term and preterm pre‐eclampsia
Melchiorre, K., Wormald, B., Leslie, K., Bhide, A., & Thilaganathan, B. (2008) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.5400 · Cited by 144
Uterine Artery Doppler in Screening for Preeclampsia and Fetal Growth Restriction
Pedroso, M. A., Palmer, K. R., Hodges, R. J., Costa, F. D. S., & Rolnik, D. L. (2018) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0038-1660777 · Cited by 141 · cited 1×
“Considering these variables and the scarcity of existing scientific evidence that showed the improvement in perinatal and maternal outcomes, the Doppler uterine artery study is not recommended as a screening test for preeclampsia among women considered at low risk due to their personal and clinical history [71, 72].”
Craici, I. M., Wagner, S. J., Bailey, K. R., Fitz-Gibbon, P. D., Wood-Wentz, C. M., Turner, S. T., Hayman, S. R., White, W. M., Brost, B. C., Rose, C. H., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01115 · Cited by 130 · cited 3×
“Increased concentrations of VEGFR-1 (capable of blocking the angiogenic action of VEGF) and the soluble form of this vascular endothelial growth factor, sFlt1(fms-like tyrosine kinase 1), a potent antagonist of VEGF action, and decreased synthesis of placental growth factor (PlGF) are associated with the predominance…”
Zanette, E. A. O., Parpinelli, M. Â., Surita, F. G., Costa, M. L., Haddad, S. M., Sousa, M. H., Silva, J. L. P. E., Souza, J. P., Cecatti, J. G., & The Brazilian Network for Surveillance of Severe Maternal Morbidity Group (2014) · Reproductive Health · doi:10.1186/1742-4755-11-4 · Cited by 129
Self-citationManagement of Hypertensive Disorders in Pregnancy
Moussa, H. N., Arian, S. E., & Sibai, B. M. (2014) · Women s Health · doi:10.2217/whe.14.32 · Cited by 128 · cited 1×
“Even today, hypertensive conditions portray important complications during the gestation, with an incidence that varies according to the particularities of the population studied, and can exceed the mark of 10% in some regions [4].”
Metabolomics and first-trimester prediction of early-onset preeclampsia
Bahado-Singh, R. O., Akolekar, R., Mandal, R., Dong, E., Xia, J., Kruger, M. L., Wishart, D. S., & Nicolaides, K. H. (2012) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2012.680254 · Cited by 127
Andrietti, S., Silva, M. D. L., Wright, A., Wright, D. E., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.15812 · Cited by 120 · cited 1×
“This proportion of pregnant women may develop preeclampsia after 32 weeks of gestation [13, 55, 56].”
Giordano, J. C., Parpinelli, M. Â., Cecatti, J. G., Haddad, S. M., Costa, M. L., Surita, F. G., Silva, J. L. P. E., & Sousa, M. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097401 · Cited by 116
Self-citationCheng, S., Chou, H., Tsou, K.-I., Fang, L.-J., & Tsao, P. (2003) · Early Human Development · doi:10.1016/j.earlhumdev.2003.10.004 · Cited by 107 · cited 1×
“Some studies have already shown a negative impact on the neurocognitive development of these infants evaluated in their first two years of life [42, 43].”
Obesity Epidemic: Impact From Preconception to Postpartum
Moussa, H. N., Alrais, M. A., Leon, M. G., Abbas, E. L., & Sibai, B. M. (2016) · Future Science OA · doi:10.4155/fsoa-2016-0035 · Cited by 104 · cited 1×
“Preexisting pathological conditions such as chronic hypertension, diabetes mellitus, nephropathy, and antiphospholipid antibody syndrome are also included in the list [21, 57], as well as BMI above 35 and use of assisted reproductive technologies [58, 59].”
Angiogenic balance (sFlt-1/PlGF) and preeclampsia
Lecarpentier, É., & Tsatsaris, V. (2016) · Annales d Endocrinologie · doi:10.1016/j.ando.2016.04.007 · Cited by 101 · cited 1×
“Increased concentrations of VEGFR-1 (capable of blocking the angiogenic action of VEGF) and the soluble form of this vascular endothelial growth factor, sFlt1(fms-like tyrosine kinase 1), a potent antagonist of VEGF action, and decreased synthesis of placental growth factor (PlGF) are associated with the predominance…”
Kalafat, E., Sukur, Y. E., Abdi, A., Thilaganathan, B., & Khalil, A. A. (2018) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.19084 · Cited by 100 · cited 1×
“On the other hand, when compared to placebo, metformin did not exhibit any beneficial effect regarding preeclampsia [48, 49].”
First-trimester metabolomic detection of late-onset preeclampsia
Bahado-Singh, R. O., Akolekar, R., Mandal, R., Dong, E., Xia, J., Kruger, M. L., Wishart, D. S., & Nicolaides, K. H. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.11.003 · Cited by 98
Utero-placental Doppler ultrasound for improving pregnancy outcome
Stampalija, T., Gyte, G. M., & Alfirević, Ž. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008363.pub2 · Cited by 95 · cited 1×
“Considering these variables and the scarcity of existing scientific evidence that showed the improvement in perinatal and maternal outcomes, the Doppler uterine artery study is not recommended as a screening test for preeclampsia among women considered at low risk due to their personal and clinical history [71, 72].”
First‐trimester prediction of preeclampsia using metabolomic biomarkers: a discovery phase study
Odibo, A. O., Goetzinger, K. R., Odibo, L., Cahill, A. G., Macones, G. A., Nelson, D. M., & Dietzen, D. J. (2011) · Prenatal Diagnosis · doi:10.1002/pd.2822 · Cited by 95
Cecatti, J. G., Costa, M. L., Sm, H., Parpinelli, M., Souza, J. P., Sousa, M. H. D., Surita, F. G., Silva, J. L. P. E., Pacagnella, R. C., Passini, R., et al. (2015) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13614 · Cited by 88 · cited 1×
“4%, which is considered an acceptable value (below 20%), but still very high, far from the ones observed in high-income countries (<2%) [9].”
Self-citationAustdal, M., Tangerås, L. H., Skråstad, R. B., Salvesen, K. Å., Austgulen, R., Iversen, A., & Bathen, T. F. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160921520 · Cited by 86
Inflammatory Markers and Preeclampsia
Black, K. D., & Horowitz, J. A. (2018) · Nursing Research · doi:10.1097/nnr.0000000000000285 · Cited by 81 · cited 1×
“However, it is still not possible to elect one isolated factor that is sufficient for a prediction of this condition [73].”
Validation of metabolomic models for prediction of early-onset preeclampsia
Bahado-Singh, R. O., Syngelaki, A., Akolekar, R., Mandal, R., Bjondahl, T. C., Han, B., Dong, E., Bauer, S., Alpay-Savasan, Z., Graham, S. F., et al. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.06.044 · Cited by 80 · cited 1×
“For this reason, the need to search for other prediction ways that include different preeclampsia syndrome phenotypes, considering the fact that the cases of late manifestation are the most frequent [78], remains.”
Assisted reproductive technologies and perinatal morbidity: interrogating the association
Barnhart, K. T. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.12.032 · Cited by 77 · cited 1×
“The latter is associated with a higher incidence of multiple pregnancies and with an increase in the average age of women in their first pregnancy, which together act to increase the occurrence of preeclampsia [60, 61].”
Chaiworapongsa, T., Yoshimatsu, J., Espinoza, J., Kim, Y. M., Berman, S., Edwin, S. S., Yoon, B. H., & Romero, R. J. (2002) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/jmf.11.6.362.367 · Cited by 76
Kuć, S., Koster, M. P. H., Pennings, J. L. A., Hankemeier, T., Berger, R., Harms, A. C., Dane, A. D., Schielen, P. C. J. I., Visser, G. H. A., & Vreeken, R. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098540 · Cited by 74
Genetics, genomics and metabolomics: new insights into maternal metabolism during pregnancy
Lowe, W. L., & Karban, J. (2013) · Diabetic Medicine · doi:10.1111/dme.12352 · Cited by 72 · cited 1×
“Metabolomics is one of these technologies used for the metabolites identification, small molecules that represent the final line of gene expression and a phenotypic signature in high resolution of the disease desired to be studied [79, 80].”
Application of metabolomics to preeclampsia diagnosis
Gh, B. F. N. M. (2018) · Systems Biology in Reproductive Medicine · doi:10.1080/19396368.2018.1482968 · Cited by 69 · cited 1×
“Metabolomics is one of these technologies used for the metabolites identification, small molecules that represent the final line of gene expression and a phenotypic signature in high resolution of the disease desired to be studied [79, 80].”
First-Trimester Serum Acylcarnitine Levels to Predict Preeclampsia: A Metabolomics Approach
Koster, M. P. H., Vreeken, R. J., Harms, A. C., Dane, A. D., Kuć, S., Schielen, P. C. J. I., Hankemeier, T., Berger, R., Visser, G. H. A., & Pennings, J. L. A. (2015) · Disease Markers · doi:10.1155/2015/857108 · Cited by 64
Management of pregnancies after combined screening for pre‐eclampsia at 19–24 weeks' gestation
Litwińska, M., Syngelaki, A., Wright, A., Wright, D. E., & Nicolaides, K. H. (2018) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.19099 · Cited by 61
Major Changes in Diagnosis and Management of Preeclampsia
SNYDAL, S. (2014) · Journal of Midwifery & Women s Health · doi:10.1111/jmwh.12260 · Cited by 60 · cited 1×
“An inquiry conducted in California in 2011, in order to investigate the increase in maternal deaths observed in that region in the early 2000s, revealed that 79% of preeclampsia related deaths were due to poor management [18, 19].”
Dysbiosis and Prematurity: Is There a Role for Probiotics?
Baldassarre, M. E., Mauro, A. D., Capozza, M., Rizzo, V., SCHETTINI, F., Panza, R., & Laforgia, N. (2019) · Nutrients · doi:10.3390/nu11061273 · Cited by 57
Serial assessment of cardiovascular control shows early signs of developing pre-eclampsia
Rang, S., Wolf, H., van Montfrans, G. A., & Karemaker, J. M. (2004) · Journal of Hypertension · doi:10.1097/00004872-200402000-00022 · Cited by 55 · cited 1×
“Considering that the average blood pressure levels are high in pregnant women who will develop preeclampsia in the first or second trimester, or even who already had it elevated before pregnancy [65, 66], this marker ceases to represent a tool for the diagnosis of hypertensive conditions and starts to act as an import…”
Cellular mRNA expressions of anti‐oxidant factors in the blood of preeclamptic women
Nakamura, M., Sekizawa, A., Purwosunu, Y., Okazaki, S., Farina, A., Wibowo, N., Shimizu, H., & Okai, T. (2009) · Prenatal Diagnosis · doi:10.1002/pd.2278 · Cited by 52 · cited 2×
“It can be said that such a process is immunomediated, as it involves systemic inflammatory response and maternal genetic predisposition [34, 36, 37].”
Pravastatin to treat and prevent preeclampsia. Preclinical and clinical studies
Girardi, G. (2017) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2017.09.009 · Cited by 50 · cited 1×
“In parallel, Pravastatin has been pointed out as a good option to prevent preeclampsia, although larger studies must be done with dose escalation to confirm its effectiveness [50, 51].”
Integrated Proteomic and Metabolomic prediction of Term Preeclampsia
Bahado-Singh, R. O., Poon, L. C., Yılmaz, A., Syngelaki, A., Türkoğlu, O., Kumar, P., Kirma, J., Allos, M., Accurti, V., Li, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15882-9 · Cited by 47
Hinton, L., Locock, L., & Knight, M. (2015) · British Journal of General Practice · doi:10.3399/bjgp15x686461 · Cited by 45
Mean arterial pressure at 12, 22, 32 and 36 weeks' gestation in screening for pre-eclampsia
Tayyar, A. T., Krithinakis, K., Wright, A., Wright, D., & Nicolaides, K. H. (2016) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.15815 · Cited by 43 · cited 1×
“This proportion of pregnant women may develop preeclampsia after 32 weeks of gestation [13, 55, 56].”
Principles of Medical Therapy in Pregnancy
Gleicher, N. (1985) · Springer eBooks · doi:10.1007/978-1-4613-2415-7 · Cited by 41
Biomarker identification and pathway analysis of preeclampsia based on serum metabolomics
Chen, T., He, P., Tan, Y., & Xu, D. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.02.032 · Cited by 38
First trimester screening cannot predict adverse outcomes yet
Halscott, T. L., Ramsey, P. S., & Reddy, U. M. (2014) · Prenatal Diagnosis · doi:10.1002/pd.4407 · Cited by 32
Sung, K. U., Roh, J. A., Eoh, K. J., & Kim, E. H. (2017) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2017.60.2.154 · Cited by 28 · cited 1×
“Furthermore, the definition of normality parameters for these markers is influenced by the presence or absence of diabetes mellitus, parity (multiparous patients have lower PAPP-A values than nulliparous patients), twinhood (who have higher levels of PAPP-A and PIGF than those observed in single pregnancies), advanced…”
Lotufo, F. A. H., Parpinelli, M. Â., Osis, M. J. D., Surita, F. G., Costa, M. L., & Cecatti, J. G. (2016) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-016-1055-0 · Cited by 25
Self-citationNgwenya, S., Jones, B., & Mwembe, D. (2019) · BMC Research Notes · doi:10.1186/s13104-019-4334-9 · Cited by 21
Benton, S. J., Ly, C., Vuković, S., & Bainbridge, S. A. (2016) · Placenta · doi:10.1016/j.placenta.2016.11.006 · Cited by 15
Ngwenya, S., Jones, B., Heazell, A. E. P., & Mwembe, D. (2019) · BMC Research Notes · doi:10.1186/s13104-019-4539-y · Cited by 8
Feig, D. S. (2018) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2018-110975 · Cited by 3 · cited 1×
“On the other hand, when compared to placebo, metformin did not exhibit any beneficial effect regarding preeclampsia [48, 49].”
Cited by
Henderson, J. T., Vesco, K. K., Senger, C. A., Thomas, R. G., & Redmond, N. (2021) · JAMA · doi:10.1001/jama.2021.8551 · Cited by 227
Metadata
- Authors
- Mayrink, J., Costa, M. L., & Cecatti, J. G.
- Venue
- The Scientific World Journal
- Publisher
- Wiley
- Published
- 2018-12-06
- Volume
- 2018
- Pages
- 1-9
- ISSN
- 1537-744X (ISSN-L)
- 2356-6140
- OpenAlex
- W2903940163
- Cited by
- 237
- References
- 95
- FWCI
- 19.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.